Remedy Sets 2026 Reporting Calendar Amid Turnaround Push

• Remedy’s Q3 2025 revenue fell to €12.2 million, with an operating loss of €16.4M, as per its latest Business Review.
• Amidst CEO Tero Virtala’s resignation, interim CEO Markus Mäki pledges to drive stronger results.
• Remedy intends to double its 2024 revenue and achieve 30% EBITDA margin by 2027.

Remedy Entertainment Plc recently announced its primary financial reporting dates for 2026, as well as the dates of its next Annual General Meeting (AGM). As per the official statement of the company, Remedy will release its Financial Statements for 2025 on February 10, 2026. 

Following the release of the financial statements, there will be a series of quarterly and half-yearly analyses throughout the year of 2026. These analyses will include Business Review for January to March of 2026 set to be released on May 5, the Half-Year Financial Report for January to June which will be out by August 11, and the Business Review for January to September which is slated to be released on November 3 of 2026.

The 2025 Annual Report will be made available through Remedy's investor website in Week 13 of 2026. Meanwhile, the Annual General Meeting (AGM) has been scheduled for Week 21 of 2026. According to reports, official summons for the same will be issued by the Board of Directors at a later date.

Remedy’s Future Targets and Ventures

While Remedy’s revenue grew by 8.9 % to €42.5 million in the January–September 2025 period, it saw a quick decline of 32.0%, amounting to €12.2M in Q3 2025, as per its latest Business Review.

For the unversed, the Business Review is a quarterly investor update, distinct from the Financial Statements, which is a rather comprehensive annual report, compiling data from all the quarters (Q1, Q2, Q3, Q4).

The Financial Statements that will be released in 2026, will provide final full-year figures about Remedy along with analysis, audit notes, and comments from the management.

On the other hand, the latest Business Review also revealed about Remedy incurring an operating loss of €16.4M. The majority of this loss was caused by a €14.9M non-cash impairment associated with its multiplayer game FBC: Firebreak.

Nevertheless, the company is anticipating more revenue in 2025, but with a smaller, negative operating profit.

Amidst this revenue pressure and resignation of Tero Virtala as the company's CEO, interim CEO Markus Mäki said, "My immediate focus is on ensuring our commercial performance alongside successful development projects."

He further added that the company is not satisfied with the financial performance. However, the company is confident about creating great video games that can resonate with the players and bring them back to profitability.

After two flagship franchises like Control and Alan Wake, the company is working on new upcoming titles. Control 2 is currently in full production, along with the Max Payne remakes. The Max Payne remakes are being developed in collaboration with Rockstar Games.

As a part of its long-term target, Remedy intends to double its revenue of 2024 (€50.7M) by 2027, while achieving an EBITDA margin of 30% by the same year, sustaining it thereafter.